Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr Farid explores ongoing and future MDC-CAR-BCMA001 trials in myeloma.
Dr. Garfall discusses the reasoning behind the Phase 2 BMT CTN 1902 trial for multiple myeloma.
Dr Bishop explains why Anito-Cel is studied in relapsed myeloma.
Dr. Joseph explores exercise and supportive care in myeloma treatment research.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr Farid explores ongoing and future MDC-CAR-BCMA001 trials in myeloma.
Dr. Garfall discusses the reasoning behind the Phase 2 BMT CTN 1902 trial for multiple myeloma.
Dr Bishop explains why Anito-Cel is studied in relapsed myeloma.
Dr. Joseph explores exercise and supportive care in myeloma treatment research.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
